Xue-jie Wu

An oncolytic adenovirus targeting TGFβ inhibits pro-tumorigenic signals and produces immune activation: A novel approach to enhance anti-PD-1 and anti-CTLA-4 therapy.

Yuan Ji, K. Mangold, P. Seth, 2019, Human gene therapy.

Baseline predictors of virological response for chronic hepatitis B patients.

Xue-jie Wu, gui-qiang Wang, Yan Wang, 2009, World journal of gastroenterology.

A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers.

Lisheng Wang, F. Xiao, Hua Wang, 2018, Cellular immunology.

Hepatoma cells up-regulate expression of programmed cell death-1 on T cells.

Xue-jie Wu, gui-qiang Wang, Ji Chen, 2008, World journal of gastroenterology.

Intrahepatic levels of PD-1/PD-L correlate with liver inflammation in chronic hepatitis B

Hong Zhao, Xue-jie Wu, gui-qiang Wang, 2010, Inflammation Research.

Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B.

Yan Wang, Jun Li, Xue-jie Wu, 2010, World journal of gastroenterology.

Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta‐analysis

D. Xiu, Xue-jie Wu, W. Rao, 2009, Transplant international : official journal of the European Society for Organ Transplantation.